These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 9576282

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation.
    Castroagudin JF, Delgado M, Martinez SM, Abdulkader I, Potel J, Tome S, Otero E, Varo E.
    Transplant Proc; 2005 Apr; 37(3):1477-9. PubMed ID: 15866645
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Percutaneous ethanol injection (PEI) for small hepatocellular carcinoma].
    Ebara M, Kita K, Nagato Y, Yoshikawa M, Sugiura N, Ohto M.
    Gan To Kagaku Ryoho; 1993 May; 20(7):884-8. PubMed ID: 8387759
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation.
    Andriulli A, de Sio I, Solmi L, De Carlis L, Troisi R, Grasso A, Festa V, Caturelli E, Giacomoni A, Del Vecchio Blanco C, De Hemptinne B, Burroughs A, Perri F.
    Liver Transpl; 2004 Nov; 10(11):1355-63. PubMed ID: 15497162
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Peng ZW, Zhang YJ, Chen MS, Liang HH, Li JQ, Zhang YQ, Lau WY.
    Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK, Wikström M, Flechtenmacher C, Filser T, Dueber C.
    Cardiovasc Intervent Radiol; 2006 Jul; 29(5):778-84. PubMed ID: 16779690
    [Abstract] [Full Text] [Related]

  • 18. Intratumor injection of absolute ethanol under ultrasound guidance for the treatment of small hepatocellular carcinoma.
    Sheu JC, Sung JL, Huang GT, Chen DS, Yang PM, Lai MY, Wei TC, Su CT, Tsang YM, Lee CZ.
    Hepatogastroenterology; 1987 Dec; 34(6):255-61. PubMed ID: 2448215
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM, Luo PF, Lin HH, Zhou ZJ, Shao PJ, Fu L, Li WK.
    Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.